SCHEMBL20053732

SCHEMBL20053732

CC(C)(F)CN1CCC(COc2ccc(-c3ccc(C(=O)N4CCCC4)c(F)c3)c(F)c2)CC1

nearest known ligand 0.45

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
PARP10 Q53GL7 2/20 0.45
PARP15 Q460N3 1/20 0.45
CPS1 P31327 3/20 0.44
KCNH2 Q12809 1/20 0.43
HRH3 Q9Y5N1 1/20 0.43
GPR119 Q8TDV5 5/20 0.42
SCN9A Q15858 2/20 0.41
HCRTR2 O43614 2/20 0.39
ALOX5AP P20292 1/20 0.39
FEN1 P39748 1/20 0.39
HCRTR1 O43613 1/20 0.38
MTOR P42345 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15537547 0.92 ALOX5AP (0.45) PARP10PARP15CPS1GPR119SCN9A
SCHEMBL15537545 0.92 ALOX5AP (0.45) PARP10PARP15CPS1GPR119SCN9A
SCHEMBL15538644 0.92 ALOX5AP (0.45) PARP10PARP15CPS1GPR119SCN9A
SCHEMBL20053607 0.91 GPR119 (0.44) PARP10PARP15CPS1KCNH2HRH3
SCHEMBL16803846 0.91 CPS1 (0.44) PARP10PARP15CPS1GPR119SCN9A
SCHEMBL20053644 0.91 GPR119 (0.40) PARP10PARP15CPS1KCNH2HRH3
SCHEMBL15537974 0.90 ALOX5AP (0.44) PARP10PARP15CPS1GPR119SCN9A
SCHEMBL15539959 0.90 ALOX5AP (0.44) PARP10PARP15CPS1GPR119SCN9A
SCHEMBL15537977 0.90 ALOX5AP (0.44) PARP10PARP15CPS1GPR119SCN9A
SCHEMBL20053739 0.90 ADRB2 (0.45) KCNH2HRH3GPR119

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2858986-B1 PIPERIDINE DERIVATIVES AS GPR119 AGONISTS CHONG KUN DANG PHARMACEUTICAL CORP (KR) 2019-10-30 EP disclosed
US-9944600-B2 Piperidine derivatives for GPR119 agonist CHONG KUN DANG PHARMACEUTICAL CORP. (KR) 2018-04-17 US disclosed